CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
BeadBlock 300 - 500 Micron +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02248688
NCT02248688N/ACompleted
CompareCT.gov

Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically (GET LEAN)

Dayton Interventional Radiology·interventional·Posted Sep 25, 2014·Updated Jan 25, 2022

In Brief

A clinical study evaluating BeadBlock 300 - 500 Micron and Left Gastric Artery Embolization for Arterial Embolization and 2 related conditions. Completed, enrolled 5 participants across 1 site.

Detailed Summary

The purpose of this pilot study is to achieve the collection of safety and efficacy data in patients undergoing left gastric artery embolization for morbid obesity in the United States. As secondary goal, the pilot study seeks to obtain quality of life data. This pilot study is not designed to achieve new indications for this device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArterial Embolization, Other Surgical Procedures, Obesity
CountriesUnited States
CollaboratorsOhio State University

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 25, 2014
Enrollment StartSep 1, 2014
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 11.8 years ago

Interventions

BeadBlock 300 - 500 Microndevice

Beadblock will be used intraarterially to occlude the left gastric artery and its branches. The left gastric artery supplies the fundus of the stomach, where it is known that the hormone Ghrelin (one of the hormones responsible for appetite) is produced.

Left Gastric Artery Embolizationprocedure